Baxter International Inc. (bax)
BAX Estimates
Public analyst price targets and consensus snapshot for Baxter International Inc.. Deeper estimate history and models are available in Vest Terminal.
| Last price | $23.49 |
| Analyst mean target | $28.73 |
| Analyst high target | $40.00 |
| Analyst low target | $23.00 |
| Upside vs mean target | 22.3% |
| Consensus recommendation | Hold |
| Number of analysts | 11 |
| Forward P/E | 11.54 |
Start Free — open BAX in Vest Terminal
Access live data, filings, ownership, and analysis for Baxter International Inc..
Baxter International Inc. FAQ
What does Baxter International Inc. (BAX) do?
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous…
What is BAX's P/E ratio?
Baxter International Inc. has a trailing P/E of N/A× based on publicly available market data.
Does BAX pay a dividend?
Indicated dividend yield: 0.2%. Confirm ex-dates and payout history in Vest Terminal.
What sector is BAX in?
Baxter International Inc. is classified in Healthcare (Medical Instruments & Supplies) on NYQ.
What is BAX's market capitalization?
Approximate market cap: $12.14B.
What are the main risks for BAX?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of BAX?
Potential positives include revenue growth of 5.3% year-over-year, earnings growth of 36.8% year-over-year.
Where can I get analyst estimates for BAX?
Public analyst price targets and consensus for Baxter International Inc. are on the free /stocks/bax/estimates page. Deeper estimate history and models are available in Vest Terminal.